查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1612807

心肺機市場：按產品、應用和最終用戶分類 - 2025 年至 2030 年全球預測

Cardiopulmonary Bypass Equipment Market by Product (Autotransfusion Systems, Heart-Lung Machines, Oxygenators), Application (Cardiovascular, Hemodialysis, Respiratory), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心肺機市場價值為3.0691億美元，預計2024年將達到3.1992億美元，複合年成長率為4.38%，到2030年將達到4.1451億美元。

心肺體外迴圈(CPB) 機器在心血管手術中非常重要，可在需要心肺支持的手術期間促進血液循環和氧合。該設備對於冠狀動脈繞道手術手術、心臟瓣膜修復和心臟移植等手術至關重要。由於生活習慣和人口老化，全球心血管疾病盛行率不斷增加，對體外循環設備的需求持續增加。醫院、心臟專科設施和門診手術中心構成了該市場的主要最終用途部分。主要成長動力包括微創手術等技術進步、病人安全的改善以及發展中地區醫療設施數量的增加。然而，市場擴張受到設備成本高、監管要求嚴格以及對熟練操作人員的需求等因素的限制。透過創新研究和開發應對這些挑戰可以開闢新的途徑。例如探索自動化和人工智慧整合系統以提高準確性並減少人為錯誤，以及開發適合新興市場的具有成本效益的模型。此外，隨著遠端醫療和遠端醫療解決方案的出現，還有可能將 CPB資料整合到更廣泛的患者管理系統中，以加強術後護理。還存在機會透過對技術人員和外科醫生使用先進設備的培訓計劃來加強客戶服務並確保提供最佳服務。然而，由於現有公司壟斷市場，競爭仍然激烈，為新參與企業設置了進入障礙。企業應專注於持續的產品創新、併購市場滲透以及與醫療機構的策略聯盟以鞏固市場地位。因此，儘管存在挑戰，但可以透過採取以創新和市場適應為中心的策略方法來緩解這些挑戰，並為 CPB 設備領域的業務成長提供有希望的途徑。

主要市場統計
基準年[2023] 30691萬美元
預測年份 [2024] 31992萬美元
預測年份 [2030] 41451萬美元
複合年成長率（%） 4.38%

市場動態：揭示快速發展的心肺機市場的關鍵市場洞察

供需的動態交互作用正在改變心肺機市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球心血管疾病盛行率上升
    • 微創手術需求增加
    • 政府努力增加衛生支出和改善衛生基礎設施
  • 市場限制因素
    • 心肺機相關的高成本
  • 市場機會
    • 整合人工智慧進行監控和預測分析
    • 持續專注於研發，開發創新且具成本效益的產品
  • 市場問題
    • 嚴格的產品核可監理要求

波特五力：駕馭心肺機市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解外部對心肺機市場的影響

外部宏觀環境因素對心肺機市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解心肺機市場競爭狀況

對心肺機市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣：心肺機市場供應商績效評估

FPNV定位矩陣是評估心肺機市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製心肺機市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，心肺機市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球心血管疾病盛行率正在上升
      • 微創手術需求增加
      • 醫療費用增加和政府改善醫療基礎設施的努力
    • 抑制因素
      • 心肺機相關的高成本
    • 機會
      • 整合人工智慧進行監控和預測分析
      • 持續專注研發，開發創新且具成本效益的產品
    • 任務
      • 嚴格的產品核可監理要求
  • 市場區隔分析
    • 產品：氧合設備的使用激增，以提高整體手術的安全性和有效性
    • 最終用戶：透析中心心肺機的高使用率
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章心肺機市場：分產品

  • 介紹
  • 自體輸血系統
  • 心肺機
  • 供氧裝置

第7章心肺機市場：依應用分類

  • 介紹
  • 心血管
  • 血液透析機
  • 呼吸系統

第8章心肺機市場：依最終用戶分類

  • 介紹
  • 透析中心
  • 醫院
  • 專科診所

第9章 美洲心肺機市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太心肺機市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲心肺機市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Inspira推出新型心肺體外迴圈設備
    • Inspira Technologies 開發了 VORTX 血液氧合器，這是一項專有技術，可使血液充滿氧氣並去除二氧化碳
    • LivaNova 用於心肺體外迴圈手術的 Essence 心肺機獲得美國FDA 510(k) 許可
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomedica
  • Brightwake Limited
  • Chalice Medical Ltd.
  • Fresenius Kabi
  • Getinge AB
  • Global Blood Resources, LLC
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • MAQUET Holding BV & Co. KG.
  • MC3 Cardiopulmonary
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Owgels Group
  • Precision Medical, Inc.
  • ProCell Surgical Inc.
  • Senko Medical Instrument Manufacturing Co.,Ltd.
  • Sorin Group
  • Stryker Corporation
  • Technowood Corporation
  • Teleflex Incorporated
  • Terumo Group
  • Xenios AG
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-757B1C9CB0B8

The Cardiopulmonary Bypass Equipment Market was valued at USD 306.91 million in 2023, expected to reach USD 319.92 million in 2024, and is projected to grow at a CAGR of 4.38%, to USD 414.51 million by 2030.

Cardiopulmonary bypass (CPB) equipment is critical in cardiac surgeries, facilitating blood circulation and oxygenation during procedures that require heart-lung function support. This equipment is indispensable in surgeries like coronary artery bypass grafting, heart valve repair, and heart transplants. As the global prevalence of cardiovascular diseases rises due to lifestyle factors and an aging population, the demand for CPB equipment continues to increase. Hospitals, cardiac institutes, and ambulatory surgical centers form the primary end-use sectors for this market. Key growth drivers include advancements in technology such as minimally invasive surgery, improved patient safety outcomes, and the rising number of healthcare facilities in developing regions. However, market expansion is constrained by factors like high costs of equipment, stringent regulatory requirements, and the need for skilled operators. Addressing these challenges through innovative research and development can open new avenues: for instance, exploring automated or AI-integrated systems to enhance precision and reduce human error, and developing cost-efficient models suitable for emerging markets. Additionally, with the advent of telehealth and remote healthcare solutions, there could be potential in integrating CPB data into broader patient management systems for enhanced post-operative care. Opportunities also exist in enhancing customer service through training programs for technicians and surgeons on advanced equipment usage, thereby ensuring optimal service delivery. However, competition remains stiff with established players dominating the market, posing entry barriers for new entrants. Companies should focus on continuous product innovation, mergers and acquisitions for market penetration, and strategic partnerships with healthcare facilities to solidify their market position. Thus, while challenges exist, they can be mitigated by adopting a strategic approach centered on technological innovation and market adaptation, providing promising avenues for business growth within the CPB equipment landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 306.91 million
Estimated Year [2024] USD 319.92 million
Forecast Year [2030] USD 414.51 million
CAGR (%) 4.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiopulmonary Bypass Equipment Market

The Cardiopulmonary Bypass Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cardiovascular diseases globally
    • Increasing demand for minimally invasive surgical procedures
    • Growing healthcare expenditure and government initiatives to improve healthcare infrastructure
  • Market Restraints
    • High cost associated with cardiopulmonary bypass equipment
  • Market Opportunities
    • Integration of artificial intelligence for monitoring and predictive analysis
    • Ongoing focus on research and development to develop innovative and cost-effective products
  • Market Challenges
    • Stringent regulatory requirements for product approval

Porter's Five Forces: A Strategic Tool for Navigating the Cardiopulmonary Bypass Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiopulmonary Bypass Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiopulmonary Bypass Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiopulmonary Bypass Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiopulmonary Bypass Equipment Market

A detailed market share analysis in the Cardiopulmonary Bypass Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiopulmonary Bypass Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiopulmonary Bypass Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiopulmonary Bypass Equipment Market

A strategic analysis of the Cardiopulmonary Bypass Equipment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiopulmonary Bypass Equipment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Brightwake Limited, Chalice Medical Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, Johnson & Johnson Services, Inc., LivaNova PLC, MAQUET Holding B.V. & Co. KG., MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corporation, Nipro Corporation, Owgels Group, Precision Medical, Inc., ProCell Surgical Inc., Senko Medical Instrument Manufacturing Co.,Ltd., Sorin Group, Stryker Corporation, Technowood Corporation, Teleflex Incorporated, Terumo Group, Xenios AG, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiopulmonary Bypass Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Autotransfusion Systems, Heart-Lung Machines, and Oxygenators.
  • Based on Application, market is studied across Cardiovascular, Hemodialysis, and Respiratory.
  • Based on End-User, market is studied across Dialysis Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiovascular diseases globally
      • 5.1.1.2. Increasing demand for minimally invasive surgical procedures
      • 5.1.1.3. Growing healthcare expenditure and government initiatives to improve healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with cardiopulmonary bypass equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence for monitoring and predictive analysis
      • 5.1.3.2. Ongoing focus on research and development to develop innovative and cost-effective products
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for product approval
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Burgeoning usage of oxygenators as it enhances overall procedure safety and effectiveness
    • 5.2.2. End-User: High usage of cardiopulmonary bypass equipment by dialysis centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiopulmonary Bypass Equipment Market, by Product

  • 6.1. Introduction
  • 6.2. Autotransfusion Systems
  • 6.3. Heart-Lung Machines
  • 6.4. Oxygenators

7. Cardiopulmonary Bypass Equipment Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. Hemodialysis
  • 7.4. Respiratory

8. Cardiopulmonary Bypass Equipment Market, by End-User

  • 8.1. Introduction
  • 8.2. Dialysis Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Cardiopulmonary Bypass Equipment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiopulmonary Bypass Equipment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiopulmonary Bypass Equipment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Inspira To Unveil New Line of Cardio-Pulmonary Bypass Devices
    • 12.3.2. Inspira Technologies is Developing the VORTX Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
    • 12.3.3. LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Becton, Dickinson and Company
  • 3. Beijing ZKSK Technology Co., Ltd.
  • 4. Braile Biomedica
  • 5. Brightwake Limited
  • 6. Chalice Medical Ltd.
  • 7. Fresenius Kabi
  • 8. Getinge AB
  • 9. Global Blood Resources, LLC
  • 10. Johnson & Johnson Services, Inc.
  • 11. LivaNova PLC
  • 12. MAQUET Holding B.V. & Co. KG.
  • 13. MC3 Cardiopulmonary
  • 14. Medtronic Plc
  • 15. MicroPort Scientific Corporation
  • 16. Nipro Corporation
  • 17. Owgels Group
  • 18. Precision Medical, Inc.
  • 19. ProCell Surgical Inc.
  • 20. Senko Medical Instrument Manufacturing Co.,Ltd.
  • 21. Sorin Group
  • 22. Stryker Corporation
  • 23. Technowood Corporation
  • 24. Teleflex Incorporated
  • 25. Terumo Group
  • 26. Xenios AG
  • 27. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. CARDIOPULMONARY BYPASS EQUIPMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CARDIOPULMONARY BYPASS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOPULMONARY BYPASS EQUIPMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY AUTOTRANSFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEART-LUNG MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. CARDIOPULMONARY BYPASS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023